| 序号 |
标题 |
次数 |
作者 |
发布时间 |
| 82981 |
PAMAM树状大分子DOTA缀合物 PAMAM–DOTA |
156 |
h |
2024-12-19 |
| 82982 |
ALD-tetra-EG-Osu的介绍 |
181 |
zyl |
2024-12-19 |
| 82983 |
SSTR2靶向肽Tyr(3)-奥曲肽(tate) |
290 |
h |
2024-12-19 |
| 82984 |
DOTA-D-Phe(1)-Tyr(3)-Octreotide |
147 |
h |
2024-12-19 |
| 82985 |
cas:55750-63-5，Mal-heptanoic NHS ester |
174 |
zyl |
2024-12-19 |
| 82986 |
DOTA-Fab-PEG24-EGF DOTA-PEG修饰曲妥珠单抗Fab片段偶联表皮生长因子 |
150 |
h |
2024-12-19 |
| 82987 |
cas:663599-10-8，DMAC-SPP |
154 |
zyl |
2024-12-19 |
| 82988 |
多甲基化的1,4,7,10-四氮杂环十二烷-1,4,7,10-四乙酸(DOTA)配体 |
200 |
h |
2024-12-19 |
| 82989 |
PEG-pGlu(DOTA)8-LA4 |
85 |
h |
2024-12-19 |
| 82990 |
cas:937025-17-7，2,5-Dioxopyrrolidin-1-yl 2-oxo-6,9,12,15-tetraoxa-3-thiaoctadecan-18-oate |
175 |
zyl |
2024-12-19 |
| 82991 |
DOTA-Hyd-TRP PET示踪剂 |
147 |
h |
2024-12-19 |
| 82992 |
Ga-DOTATOC Ga-DOTA-D-Phe-Tyr-奥曲肽 |
212 |
h |
2024-12-19 |
| 82993 |
cas:1226371-65-8，N-(2-(2,5-Dimethylphenoxy)ethyl)-4-formylbenzamide |
122 |
zyl |
2024-12-19 |
| 82994 |
DOTA-ALN DOTA-阿仑膦酸盐 |
123 |
h |
2024-12-19 |
| 82995 |
氨氯地平DOTA偶联物 DOTA-Amlodipine |
224 |
h |
2024-12-19 |
| 82996 |
cas:906564-59-8，Propargyl-C2-NHS ester |
136 |
zyl |
2024-12-19 |
| 82997 |
DOTA-Gp2-EGFR DOTA螯合剂标记结合表皮生长因子受体EGFR靶向Gp2 |
118 |
h |
2024-12-19 |
| 82998 |
cas:894095-98-8，β-D-glucuronide-pNP-carbonate |
124 |
zyl |
2024-12-19 |
| 82999 |
DOTA结合肽功能化金纳米粒子 |
142 |
h |
2024-12-19 |
| 83000 |
90Y-DOTA-Bn 钇-90-DOTA-铃蟾肽 |
200 |
h |
2024-12-19 |
| 83001 |
cas:85916-13-8，NH-bis(C1-Boc)，亚氨基二乙酸二异丁酯 |
168 |
zyl |
2024-12-19 |
| 83002 |
Anti-CD19 (clone huB4)-Mc-MMAF-ADC分子 |
94 |
zyl |
2024-12-19 |
| 83003 |
Boc-Val-Cit-PAB-PNP cas:870487-10-8 |
102 |
zyl |
2024-12-19 |
| 83004 |
cas:2353409-70-6 MMAF-methyl ester |
217 |
zyl |
2024-12-19 |
| 83005 |
DOTA-ipilimumab 螯合剂DOTA缀合单克隆抗体ipilimumab |
140 |
h |
2024-12-19 |
| 83006 |
双功能单膦酸Ln-DOTA衍生物 |
151 |
h |
2024-12-19 |
| 83007 |
Cu-DOTA-阿伦膦酸盐 Cu-DOTA-alendronate |
138 |
h |
2024-12-19 |
| 83008 |
Mc-3377的介绍 |
116 |
zyl |
2024-12-19 |
| 83009 |
Endo-BCN-PEG4-Val-Cit-PAB-MMAF的介绍 |
115 |
zyl |
2024-12-19 |
| 83010 |
(DOTA)n-PAMAM-[尼妥珠单抗-F(ab’)2]的缀合物 |
123 |
h |
2024-12-19 |
| 83011 |
cas:2055041-39-7 Mal-PEG4-Val-Cit-PAB-OH |
155 |
zyl |
2024-12-19 |
| 83012 |
DBCO-PEG3-Val-Cit-PAB-PNP的介绍 |
175 |
zyl |
2024-12-19 |
| 83013 |
(DOTA)5-十氢赖氨酸(DOTA)5-decalysine |
175 |
h |
2024-12-19 |
| 83014 |
DOTA-HPMA缀合物 DOTA共轭N-(2-羟丙基)甲基丙烯酰胺聚合物 |
152 |
h |
2024-12-19 |
| 83015 |
G3-cNGR肽缀合物 |
170 |
h |
2024-12-19 |
| 83016 |
DOTA-USMSN DOTA偶联介孔二氧化硅纳米颗粒 |
127 |
h |
2024-12-19 |
| 83017 |
Gd-DOTA-CC9 环肽CC9偶联Gd-DOTA |
185 |
h |
2024-12-19 |
| 83018 |
DOTA-尼妥珠单抗缀合物 DOTA-NIM |
104 |
h |
2024-12-19 |
| 83019 |
DOTA功能化杯[4]芳烃 DOTA-Calix[4]arenes |
123 |
h |
2024-12-19 |
| 83020 |
DOTA-Modified 2-Hydroxypropyl-β-Cyclodextrin/4-Sulfobutyl Ether-β-Cyclodextrin-Based Polyrotaxanes |
88 |
h |
2024-12-19 |
| 83021 |
CQDs-DOTA-Eu 铕-DOTA螯合物功能化碳量子点 |
189 |
h |
2024-12-19 |
| 83022 |
DOTA-曲普瑞林 DOTA-TRP |
122 |
h |
2024-12-19 |
| 83023 |
DOTA-Boron-ENPY 大环DOTA偶联16氨基酸的NPY衍生物 |
158 |
h |
2024-12-19 |
| 83024 |
DOTA-CDP1 DOTA功能化凯萨林菌素衍生肽 |
151 |
h |
2024-12-19 |
| 83025 |
Fe3O4@SiO2-APTES-DOTA-Teniposide 氧化铁@二氧化硅核壳纳米粒子偶联DOTA分子共轭替尼泊苷药物 |
202 |
h |
2024-12-19 |
齐岳微信公众号
官方微信
库存查询